HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
TerminatedEUCTR 2012-004169-42

Interventional, open-label, long-term extension study to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in patients with major depressive disorder.

This historical record does not confirm current site availability.

Historical research recordMultiple countriesDepression
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with depression. Other eligibility criteria apply.

Listed locations
Bulgaria · Estonia and 9 more locations
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Terminated
Enrollment listed in the registry
1,184
Sponsor
H. Lundbeck A/S
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United Kingdom, Bulgaria, Estonia, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2012-004169-42
Official title
Show the full official title

Interventional, open-label, long-term extension study to evaluate the safety and tolerability of brexpiprazole as adjunctive treatment in patients with major depressive disorder.

Recruitment & locations

Terminated

Bulgaria · Estonia · Finland

8 more locations
  • Germany
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Slovakia
  • Sweden
  • United Kingdom
Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is H. Lundbeck A/S.

Who can participate?

This study is for people with depression. Other eligibility criteria apply.

Is this study still recruiting?

The historical registry lists this study as terminated.

Want to explore more studies?

Explore studies